Global Pediatric Vaccines Market- 2020-2027
Global Pediatric Vaccines Market is segmentation By Disease type (Infectious Diseases (Polio, Influenza, Measles, Mumps and Rubella (MMR), Pneumococcal disease, Human papillomavirus, Hepatitis, Others), Allergies), By Vaccine Type (Monovalent Vaccines, Multivalent Vaccines), By Technology (Live attenuated Vaccines, Inactivated Vaccines, Sub-unit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2020-2027
Market Overview
The Global Pediatric Vaccines Market is expected to grow at a CAGR of 10.1% during the forecasting period (2020-2027).
Why Purchase the Report?
Visualize the composition of the Pediatric Vaccines Market products across each product type and application highlighting the critical commercial assets and players.
Identify commercial opportunities in the Pediatric Vaccines Market by analyzing trends and co-development deals.
Comprehensive details on factors driving the market growth.
Excel data sheet with thousands of data points of Pediatric Vaccines Market segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Target Audience
Industry Investors/Investment Bankers
Suppliers/Buyers
Education & Research Institutes
Manufacturers
Research Professionals
Emerging Companies
Distributors
- 1.Global Pediatric Vaccines Market Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Global Pediatric Vaccines Market – Market Definition and Overview
- 3. Global Pediatric Vaccines Market – Executive Summary
- 3.1. Market Snippet by Condition
- 3.2. Market Snippet by disease type
- 3.3. Market Snippet by vaccine type
- 3.4. Market Snippet by technology
- 3.5. DataM CLO Scenario
- 4. Global Pediatric Vaccines Market – Market Dynamics
- 4.1. Market Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Rising incidence of chronic and infectious diseases
- 4.1.1.2. Favorable government and non-government initiatives
- 4.1.1.3. Driver 3
- 4.1.2. Restraints
- 4.1.2.1. Limited availability of health-care services
- 4.1.3. Impact Analysis
- 5. Global Pediatric Vaccines Market – Industry Analysis
- 5.1. Porter's Five Forces Analysis
- 5.2. Regulatory Analysis
- 5.3. Pricing Analysis
- 5.4. Key Companies to Watch
- 5.5. Epidemiology
- 6. Global Pediatric Vaccines Market – By Disease type
- 6.1. Introduction
- 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease type
- 6.3. Market Attractiveness Index, By Disease type
- 6.4. Infectious Diseases
- 6.4.1. Introduction
- 6.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 6.4.3. Polio
- 6.4.4. Influenza
- 6.4.5. Measles, Mumps and Rubella (MMR)
- 6.4.6. Pneumococcal disease
- 6.4.7. Human papillomavirus
- 6.4.8. Hepatitis
- 6.4.9. Others
- 6.5. Allergies
- 7. Global Pediatric Vaccines Market – By Vaccine Type
- 7.1. Introduction
- 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Vaccine type
- 7.3. Market Attractiveness Index, By Vaccine type
- 7.4. Monovalent Vaccines
- 7.4.1. Introduction
- 7.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
- 7.5. Multivalent Vaccines
- 8. Global Pediatric Vaccines Market – By Technology
- 8.1. Introduction
- 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
- 8.3. Market Attractiveness Index, By Technology
- 8.4. Live attenuated Vaccines
- 8.4.1. Introduction
- 8.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
- 8.5. Inactivated Vaccines
- 8.6. Sub-unit Vaccines
- 8.7. Toxoid Vaccines
- 8.8. Conjugate Vaccines
- 8.9. Others
- 9. Global Pediatric Vaccines Market – By Region
- 9.1. Introduction
- 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
- 9.3. Market Attractiveness Index, By Region
- 9.4. North America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By disease type
- 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Vaccine type
- 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By technology
- 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 9.4.6.1. U.S.
- 9.4.6.2. Canada
- 9.4.6.3. Mexico
- 9.5. Europe
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By disease type
- 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Vaccine type
- 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By technology
- 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 9.5.6.1. Germany
- 9.5.6.2. U.K.
- 9.5.6.3. France
- 9.5.6.4. Italy
- 9.5.6.5. Spain
- 9.5.6.6. Rest of Europe
- 9.6. South America
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By disease type
- 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Vaccine type
- 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By technology
- 9.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 9.6.6.1. Brazil
- 9.6.6.2. Argentina
- 9.6.6.3. Rest of South America
- 9.7. Asia-Pacific
- 9.7.1. Introduction
- 9.7.2. Key Region-Specific Dynamics
- 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By disease type
- 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Vaccine type
- 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By technology
- 9.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 9.7.6.1. China
- 9.7.6.2. India
- 9.7.6.3. Japan
- 9.7.6.4. Australia
- 9.7.6.5. Rest of Asia Pacific
- 9.8. Middle East and Africa
- 9.8.1. Introduction
- 9.8.2. Key Region-Specific Dynamics
- 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By disease type
- 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Vaccine type
- 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By technology
- 10. Global Market – Competitive Landscape
- 10.1. Competitive Scenario
- 10.2. Competitor Pediatric vaccines Strategy Analysis
- 10.3. Comparative Product Portfolio Analysis
- 10.4. Market Positioning/Share Analysis
- 10.5. Mergers and Acquisitions Analysis
- 11. Company Profiles
- 11.1. Sanofi Pasteur
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Key Highlights
- 11.1.4. Financial Overview
- 11.2. Pfizer
- 11.3. Merck &co
- 11.4. Johnson and Johnson
- 11.5. AstraZeneca
- 11.6. Novartis
- 11.7. Eli Lilly Company
- 11.8. Bavarian Nordic
- 11.9. Sinovac Biotech
- 11.10. Indian Immunological limited
- 11.11. Panacea Biotec
- 11.12. Crucell
- 11.13. Bharat Biotech
- 11.14. Baxter
- 11.15. Dynavax Technologies
- 11.16. Takeda Pharmaceuticals
- 12. Global Pediatric Vaccines Market – Premium Insights
- 13. Global Pediatric Vaccines Market – DataM
- 13.1. Appendix
- 13.2. About Us and Services
- 13.3.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook